Treatment with Smyd3-ASOs suppressed liver tumor growth in a mouse model of chemical-induced hepatocellular carcinoma and inhibited the tumor growth rate, migration, and capacity by blocking cellular dedifferentiation and the expansion of hepatic cancer stem cells98. The gene discussed is SMYD3; the disease is hepatocellular carcinoma.